ENDOMETRIAL ADENOSQUAMOUS CARCINOMA

Clinical trials for ENDOMETRIAL ADENOSQUAMOUS CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL ADENOSQUAMOUS CARCINOMA trials appear

Sign up with your email to follow new studies for ENDOMETRIAL ADENOSQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Three-Way drug fight against advanced uterine cancer

Disease control Ongoing

This study aims to find the most effective drug combination for controlling advanced or recurrent endometrial cancer. It enrolled 349 patients to test three different mixes of chemotherapy and targeted therapy drugs. The goal is to see which combination best slows cancer growth a…

Matched conditions: ENDOMETRIAL ADENOSQUAMOUS CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

ENDOMETRIAL ADENOSQUAMOUS CARCINOMA

Get alerted when new ENDOMETRIAL ADENOSQUAMOUS CARCINOMA trials appear

Three-Way drug fight against advanced uterine cancer